SL Science Holding SLBT
NASDAQ SLBT
$1.21 +0.02 (+1.68%)
At close: Oct 28, 2026 · 4:00 PM EDT

SL Science Holding (SLBT) Receivables - Other (2025)

Updated

Analysis

SL Science Holding (SLBT) Receivables - Other (2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,155.79 Bn 1,124.38 Bn 19.71 Bn
2 Johnson & Johnson 654.21 Bn 574.07 Bn 17.30 Bn
3 AbbVie 506.54 Bn 479.65 Bn 12.70 Bn
4 Merck 347.85 Bn 302.23 Bn 12.21 Bn
5 Novartis Ag 302.74 Bn 275.97 Bn -
6 Astrazeneca 262.84 Bn 236.53 Bn 12.86 Bn
7 Amgen 244.09 Bn 199.48 Bn 7.24 Bn
8 Gilead Sciences 198.21 Bn 172.41 Bn 6.22 Bn
9 Pfizer 167.64 Bn 114.28 Bn 10.94 Bn
10 SL Science Holding 2.69 Bn 2.68 Bn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 286.00
API Access

SL Science Holding Receivables - Other API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-other&ticker=SLBT&period=max&api_key=YOUR_API_KEY